A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
Steady: 1 in the last 7 days
Updated sunday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Major pharmaceutical companies are competing for investment capital.Sub-event
Major pharmaceutical companies are noted as peers in the regulated industry.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Bristol-Myers Squibb
American pharmaceutical company
-
Amgen
American multinational biopharmaceutical company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
- Syndax Pharmaceuticals and AbbVie are competing in the healthcare and biopharma sector.
- AbbVie, Boehringer Ingelheim, and Pfizer were present at a clinical conference in Las Vegas.
- Multiple major pharmaceutical companies were identified as industry peers for growth during a capital markets day.
- AbbVie and Eli Lilly are competing in the pharmaceutical market.
- Bristol-Myers Squibb and Johnson & Johnson are both companies that are currently targets of LB Pharmaceuticals.